In-vitro activity of piperacillin/tazobactam relative to other antibiotics against blood culture isolates
- 1 July 1998
- journal article
- research article
- Published by Springer Nature in Irish Journal of Medical Science
- Vol. 167 (3) , 155-159
- https://doi.org/10.1007/bf02937928
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Nomenclature of TEM beta-lactamasesJournal of Antimicrobial Chemotherapy, 1997
- Antimicrobial-Drug ResistanceNew England Journal of Medicine, 1996
- Emerging Resistance to Antimicrobial Agents in Gram-Positive BacteriaDrugs, 1996
- National survey of the in vitro spectrum of piperacillin-tazobactam tested against more than 40,000 aerobic clinical isolates from 236 medical centersDiagnostic Microbiology and Infectious Disease, 1995
- Comparative antimicrobial activity of piperacillin-tazobactam tested against more than 5000 recent clinical isolates from five medical centers a reevaluation after five yearsDiagnostic Microbiology and Infectious Disease, 1995
- A major outbreak of methicillin-resistant Staphylococcus aureus caused by a new phage-type (EMRSA-16)Journal of Hospital Infection, 1995
- Multicenter evaluation of the in vitro activity of piperacillin-tazobactam compared with eleven selected β-lactam antibiotics and ciprofloxacin against more than 42,000 aerobic gram-positive and gram-negative bacteriaDiagnostic Microbiology and Infectious Disease, 1994
- Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococciEuropean Journal of Clinical Microbiology & Infectious Diseases, 1994
- Major trends in the microbial etiology of nosocomial infectionThe American Journal of Medicine, 1991
- The prevalence of staphylococcal resistance to penicillinase-resistant penicillinsDiagnostic Microbiology and Infectious Disease, 1989